Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Kun Wang
Lingge Feng
Jiayi Zhang
Quanfei Zou
Fengyan Xu
Zhongyi Sun
Fuxing Tang
Li Chen
机构：
[1] Shanghai Qiangshi Information Technology Co.,
[2] Ltd.,undefined
[3] Hua Medicine (Shanghai) Limited,undefined
来源：
Clinical Pharmacokinetics | 2023年 / 62卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1413 / 1425
页数：12
相关论文
共 50 条
  • [1] Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus
    Wang, Kun
    Feng, Lingge
    Zhang, Jiayi
    Zou, Quanfei
    Xu, Fengyan
    Sun, Zhongyi
    Tang, Fuxing
    Chen, Li
    [J]. CLINICAL PHARMACOKINETICS, 2023, 62 (10) : 1413 - 1425
  • [2] Population Pharmacokinetic Model for Ertugliflozin in Healthy Subjects and Patients With Type 2 Diabetes Mellitus
    Fediuk, Daryl J.
    Zhou, Susan
    Dawra, Vikas Kumar
    Sahasrabudhe, Vaishali
    Sweeney, Kevin
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (07): : 696 - 706
  • [3] Population pharmacokinetic analysis of dapagliflozin in healthy and subjects with type 2 diabetes mellitus.
    Feng, Y.
    Zhang, L.
    Komoroski, B.
    Pfister, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S93 - S93
  • [4] Population Pharmacokinetic Modeling of Canagliflozin in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus
    Hoeben, Eef
    De Winter, Willem
    Neyens, Martine
    Devineni, Damayanthi
    Vermeulen, An
    Dunne, Adrian
    [J]. CLINICAL PHARMACOKINETICS, 2016, 55 (02) : 209 - 223
  • [5] Population Pharmacokinetic Modeling of Canagliflozin in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus
    Eef Hoeben
    Willem De Winter
    Martine Neyens
    Damayanthi Devineni
    An Vermeulen
    Adrian Dunne
    [J]. Clinical Pharmacokinetics, 2016, 55 : 209 - 223
  • [6] Population Pharmacokinetic (POPPK) Model for Ertugliflozin in Healthy Subjects and Type 2 Diabetes Mellitus (T2DM) Patients
    Fediuk, Daryl J.
    Sweeney, Kevin
    Zhou, Susan
    Kumar, Vikas
    Sahasrabudhe, Vaishali
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S25 - S25
  • [7] Population Pharmacokinetic Modeling of Dasiglucagon in Subjects with Type 1 Diabetes Mellitus
    Knudsen, Carsten B.
    Valeur, Anders H.
    Maarbjerg, Stine Just
    Tehranchi, Ramin
    Diderichsen, Paul Matthias
    Witjes, Han
    [J]. DIABETES, 2021, 70
  • [8] POPULATION PHARMACOKINETIC MODELING OF DASIGLUCAGON IN SUBJECTS WITH TYPE I DIABETES MELLITUS
    Knudsen, C.
    Valeur, A.
    Maarbjerg, S.
    Diderichsen, P.
    Witjes, H.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A178 - A178
  • [9] POPULATION PHARMACOKINETIC ANALYSIS OF DAPAGLI-FLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Hong, Y.
    Roy, A.
    Boulton, D.
    LaCreta, F.
    Parikh, S.
    List, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S43 - S43
  • [10] Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer
    Gupta, Anubha
    Jarzab, Barbara
    Capdevila, Jaume
    Shumaker, Robert
    Hussein, Ziad
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (06) : 1124 - 1133
12345